Digby Jones

Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom.

DRP (UK) Ltd. operates as an integrated communications agency and multi-channel production company. The firm’s services include research and insights, creative campaigns, design, digital, video and motion graphics, events, exhibition, reward and recognition. It also offers change management communications, team and leadership development, brand awareness, employee engagement, increase sales and recruitment marketing. The company was founded by Dale Parmenter in 1980 and is headquartered in Hartlebury, the United Kingdom.

Thatchers Cider Co. Ltd. is a British company that specializes in producing cider. The private company is based in Sandford, UK, where it has been making cider since 1904. The company has over 115 years of expertise in producing cider, and it prides itself on being a family-owned business that has been passed down through four generations. Thatchers Cider Co. was founded by William John Thatcher and is currently led by CEO Martin Thatcher.

One Asset Ltd. is a British company that was founded in 2006. The private company is based in Birmingham, UK. The company engages in licensing of intellectual property and development & distributes light emitting diode displays. and has subsidiaries in United Kingdom.

Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom.

Part of Argentex Group Plc, Argentex Capital Ltd. is a foreign exchange company based in London, UK. The team consists of experienced market professionals who handle account management, analysis, trading, settlements, and compliance. The British company has a Modern Slavery Act Statement and complies with the QCA Code. In FY20, the company's revenue increased to £28.9m and its operating profit increased to £12.5m. The company was founded in 2019 and offers simple currency exchange services to clients.

DRP Holdings Ltd. provides investment services. The private company is based in Kidderminster, UK and was founded in 2002.